Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nordhealth ASOSL:NORDH +2.52%72 EV-to-FCF is -22.61 as of Jul. 24, 2026. GuruFocus rates OSL:NORDH with a GF Score™ of 72/100 and a GF Value™ of kr39.31 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 404 Healthcare Providers & Services companies, Nordhealth AS ranks worse than 247524.5% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Nordhealth AS's Enterprise Value is kr1,759.2 Mil.
Nordhealth AS's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was kr-77.8 Mil. Therefore, Nordhealth AS's EV-to-FCF for today is -22.61.
The historical rank and industry rank for Nordhealth AS's EV-to-FCF or its related term are showing as below:
OSL:NORDH'
s EV-to-FCF Range Over the Past 10 Years
Min: -641.54 Med: -23.06 Max: -6.42
Current: -20.5
During the past 6 years, the highest EV-to-FCF of Nordhealth AS was -6.42. The lowest was -641.54. And the median was -23.06.
OSL:NORDH's EV-to-FCF is ranked worse than 100% of 404
companies
in the Healthcare Providers & Services industry
Industry Median: 17.91
vs OSL:NORDH: -20.50
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Nordhealth AS's PE Ratio (TTM) for today is calculated as:
Nordhealth AS's share price for today is kr24.40.
Nordhealth AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-2.223.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Nordhealth AS EV-to-FCF Related Terms
Nordhealth AS EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Nordhealth AS's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:NORDH vs VEEV, BTSG, TEM: EV-to-FCF Comparison
For the Health Information Services subindustry, Nordhealth AS's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nordhealth AS EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nordhealth AS's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Nordhealth AS's EV-to-FCF falls into.
Nordhealth AS's current Enterprise Value is kr1,759.2 Mil.
Nordhealth AS's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-77.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nordhealth AS (OSL:NORDH) has a EV-to-FCF of -22.61 as of Jul. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Nordhealth AS and its competitors. According to the industry distribution chart, Nordhealth AS ranks #999999 out of 404 companies in the Healthcare Providers & Services industry.
Is Nordhealth AS's EV-to-FCF too high?
Nordhealth AS's current EV-to-FCF is -22.61. Based on the distribution chart, Nordhealth AS ranks #999999 out of 404 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Nordhealth AS has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nordhealth AS's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Nordhealth AS ranks #999999 out of 404 companies for EV-to-FCF. This places Nordhealth AS in the lower half of its industry. The industry median EV-to-FCF is 17.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.91, based on 404 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Nordhealth AS and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nordhealth AS's current EV-to-FCF is -22.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nordhealth AS stock overvalued right now?
Based on GuruFocus' analysis, Nordhealth AS (OSL:NORDH) is currently considered Significantly Undervalued. The stock's GF Value™ is kr39.31, compared to a current price of kr24.40 — trading 37.9% below its estimated fair value. The current EV-to-FCF is -22.61. Nordhealth AS's overall GF Score™ is 72/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Nordhealth AS (OSL:NORDH), the current EV-to-FCF is -22.61 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nordhealth AS (OSL:NORDH) Overvalued in 2026?
Based on GuruFocus' analysis, Nordhealth AS stock appears to be undervalued.
The current stock price of kr24.40 is trading 37.9% below its estimated GF Value™ of kr39.31.
GuruFocus considers Nordhealth AS to be Significantly Undervalued.
Key valuation signals for OSL:NORDH:
EV-to-FCF: -22.61
GF Value™: kr39.31 vs. price of kr24.40 (37.9% below fair value)
No single metric tells the full story. See the OSL:NORDH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nordhealth AS is a cloud-based healthcare Software-as-a-Service business. Its flagship Practice Management Software (PMS), Provet for veterinary practices and Therapy Unified Platform for therapy practices, assist healthcare professionals to streamline operations and improve patient care. The majority of its revenue is generated through software subscriptions. The Group also offers additional services related to the implementation of the SaaS systems, including consultancy services, education, and data conversion. Its operating segments are: Veterinary, which generates the majority of revenue, Therapy, and Other. Geographically, Nordhealth derives maximum revenue from Norway, and the rest from Finland, the United Kingdom, Sweden, Denmark, the DACH region, and other countries.
72GF Score
Get the complete analysis for OSL:NORDH
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:NORDH has been successfully added to your 
